In adults, higher blood levels of EPA/DHA omega-3 have been associated with a significantly lower risk for psychological distress, depression, cognitive impairment, age-related dementia, certain cancers and various other disorders.
The OmegaScore® is a very strong indicator of the risk for sudden cardiac death based on published studies from the Harvard School of Public Health in the New England Journal of Medicine.1 Furthermore, a high OmegaScore® is related to a reduced risk for “all-cause mortality”2 and “cognitive deterioration with aging”3; all of which will be provided to you in an easy to interpret report.
If the lab results indicate a low OmegaScore®, individuals can initiate an increased intake of omega-3 fatty acids from food sources (e.g. fish/seafood) and/or supplements containing EPA/DHA. If the latter intake modifications are done on a regular basis, one can expect their OmegaScore® to be favourably altered to be in the low risk zone for the above health conditions. Re-testing can be done after 4-8 weeks to confirm entry into the “low risk” zones.
** Taxes and Shipping included inside Canada
** Extra shipping fees will apply outside of Canada (email info@bechamphealth.com for more info)
For more information and to download a sample report, click here:
https://www.canaltlabs.com/wholebloodomega